Kling Bio has announced a major step forward in the field of antibody discovery, unveiling a new collaboration and...
Read MoreAkari Therapeutics has reaffirmed its strategic focus on developing its novel PH1 spliceosome modulator payload, a promising innovation in...
Read MoreA transformative new health initiative has begun across the North East and North Cumbria as NHS leaders roll out...
Read MoreSeaport Therapeutics has officially dosed the first patient in its eagerly anticipated phase 2b BUOY-1 trial of GlyphAllo, a...
Read MoreIn a significant leap forward for the field of bacteriophage therapy, BiomX has published promising results from its phase...
Read MoreBiotech company Osivax has reached a significant milestone in its mission to transform influenza prevention, with new phase 2a...
Read More